Calamos Wealth Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-6,258
| Closed | -$562K | – | 271 |
|
|
2020
Q1 | $562K | Sell |
6,258
-22,574
| -78% | -$2.03M | 0.09% | 142 |
|
|
2019
Q4 | $3.12M | Buy |
28,832
+241
| +0.8% | +$26.1K | 0.37% | 70 |
|
|
2019
Q3 | $2.8M | Buy |
28,591
+498
| +2% | +$48.8K | 0.37% | 74 |
|
|
2019
Q2 | $3.68M | Buy |
28,093
+583
| +2% | +$76.4K | 0.5% | 57 |
|
|
2019
Q1 | $3.72M | Buy |
27,510
+4,834
| +21% | +$653K | 0.53% | 56 |
|
|
2018
Q4 | $2.21M | Buy |
+22,676
| New | +$2.21M | 0.33% | 70 |
|
|
2016
Q4 | – | Sell |
-5,695
| Closed | -$698K | – | 234 |
|
|
2016
Q3 | $698K | Sell |
5,695
-6,658
| -54% | -$816K | 0.12% | 164 |
|
|
2016
Q2 | $1.44M | Sell |
12,353
-490
| -4% | -$57.2K | 0.25% | 131 |
|
|
2016
Q1 | $1.79M | Buy |
12,843
+907
| +8% | +$126K | 0.34% | 94 |
|
|
2015
Q4 | $2.28M | Buy |
11,936
+5,651
| +90% | +$1.08M | 0.45% | 62 |
|
|
2015
Q3 | $983K | Buy |
6,285
+3,813
| +154% | +$596K | 0.24% | 142 |
|
|
2015
Q2 | $447K | Buy |
+2,472
| New | +$447K | 0.11% | 184 |
|